These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1715547)

  • 1. Bradycardia-dependent early afterdepolarizations in a patient with QTU prolongation and torsade de pointes in association with marked bradycardia and hypokalemia.
    Shimizu W; Tanaka K; Suenaga K; Wakamoto A
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1105-11. PubMed ID: 1715547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations.
    Habbab MA; el-Sherif N
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):916-31. PubMed ID: 1376904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early afterdepolarizations and arrhythmogenesis. Experimental and clinical aspects.
    el-Sherif N
    Arch Mal Coeur Vaiss; 1991 Feb; 84(2):227-34. PubMed ID: 1708655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine-induced long QTU interval and torsade de pointes: role of bradycardia-dependent early afterdepolarizations.
    el-Sherif N; Bekheit SS; Henkin R
    J Am Coll Cardiol; 1989 Jul; 14(1):252-7. PubMed ID: 2738268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias.
    el-Sherif N; Zeiler RH; Craelius W; Gough WB; Henkin R
    Circ Res; 1988 Aug; 63(2):286-305. PubMed ID: 3396153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monophasic action potentials in patients with torsades de pointes.
    Miwa S; Inoue T; Yokoyama M
    Jpn Circ J; 1994 Apr; 58(4):248-58. PubMed ID: 8051783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragmented endocardial signals and early afterdepolarizations during torsades de pointes tachycardia.
    Li GL; Saguner AM; Fontaine GH; Frank R
    Cardiol J; 2020; 27(1):54-61. PubMed ID: 30009377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart.
    Asano Y; Davidenko JM; Baxter WT; Gray RA; Jalife J
    J Am Coll Cardiol; 1997 Mar; 29(4):831-42. PubMed ID: 9091531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
    Carlsson L; Abrahamsson C; Drews L; Duker G
    Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration-induced action potential prolongation and early afterdepolarizations.
    Burashnikov A; Antzelevitch C
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):934-48. PubMed ID: 9786074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic and electrophysiologic studies in patients with torsades de pointe--role of monophasic action potentials.
    Ohe T; Kurita T; Aihara N; Kamakura S; Matsuhisa M; Shimomura K
    Jpn Circ J; 1990 Oct; 54(10):1323-30. PubMed ID: 2277411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torsades de Pointes: a cause of syncope in sinus node dysfunction].
    Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S
    Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of early afterdepolarization in familial long QTU syndrome and torsade de pointes.
    Zhou JT; Zheng LR; Liu WY
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2164-8. PubMed ID: 1279619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.
    Verduyn SC; Vos MA; van der Zande J; van der Hulst FF; Wellens HJ
    Cardiovasc Res; 1997 Jun; 34(3):453-63. PubMed ID: 9231028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
    Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.